Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-010830
Filing Date
2023-07-05
Accepted
2023-07-05 17:57:50
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form4-07052023_090745.html 4  
1 form4-07052023_090745.xml 4 3645
  Complete submission text file 0001415889-23-010830.txt   5059
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Issuer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Enyedy Mark J (Reporting) CIK: 0001586965 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17999 | Film No.: 231071073